KR100336645B1 - The composites of raw-type tea containing chitosan - Google Patents
The composites of raw-type tea containing chitosan Download PDFInfo
- Publication number
- KR100336645B1 KR100336645B1 KR1020000062363A KR20000062363A KR100336645B1 KR 100336645 B1 KR100336645 B1 KR 100336645B1 KR 1020000062363 A KR1020000062363 A KR 1020000062363A KR 20000062363 A KR20000062363 A KR 20000062363A KR 100336645 B1 KR100336645 B1 KR 100336645B1
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- germinated
- chitosan
- raw
- type tea
- Prior art date
Links
- 229920001661 Chitosan Polymers 0.000 title claims abstract description 56
- 241001122767 Theaceae Species 0.000 title 1
- 239000002131 composite material Substances 0.000 title 1
- 244000269722 Thea sinensis Species 0.000 claims abstract description 36
- 239000000203 mixture Substances 0.000 claims abstract description 28
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 12
- 240000005979 Hordeum vulgare Species 0.000 claims abstract description 9
- 235000007340 Hordeum vulgare Nutrition 0.000 claims abstract description 9
- 239000004310 lactic acid Substances 0.000 claims abstract description 6
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 6
- 240000007594 Oryza sativa Species 0.000 claims abstract description 5
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 5
- 235000009566 rice Nutrition 0.000 claims abstract description 5
- 239000000843 powder Substances 0.000 claims description 24
- 235000021329 brown rice Nutrition 0.000 claims description 15
- 241001474374 Blennius Species 0.000 claims description 10
- 240000000599 Lentinula edodes Species 0.000 claims description 8
- 230000035784 germination Effects 0.000 claims description 7
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 6
- 235000021307 Triticum Nutrition 0.000 claims description 6
- 240000007124 Brassica oleracea Species 0.000 claims description 5
- 235000003899 Brassica oleracea var acephala Nutrition 0.000 claims description 5
- 235000012905 Brassica oleracea var viridis Nutrition 0.000 claims description 5
- 244000000626 Daucus carota Species 0.000 claims description 5
- 235000002767 Daucus carota Nutrition 0.000 claims description 5
- 240000008620 Fagopyrum esculentum Species 0.000 claims description 5
- 235000009419 Fagopyrum esculentum Nutrition 0.000 claims description 5
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 5
- 235000011613 Pinus brutia Nutrition 0.000 claims description 5
- 241000018646 Pinus brutia Species 0.000 claims description 5
- 235000011684 Sorghum saccharatum Nutrition 0.000 claims description 5
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 5
- 240000001417 Vigna umbellata Species 0.000 claims description 5
- 235000011453 Vigna umbellata Nutrition 0.000 claims description 5
- 240000008042 Zea mays Species 0.000 claims description 5
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 5
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 5
- 229940013618 stevioside Drugs 0.000 claims description 5
- 235000019202 steviosides Nutrition 0.000 claims description 5
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims description 4
- 235000007215 black sesame Nutrition 0.000 claims description 4
- 235000005822 corn Nutrition 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 235000000832 Ayote Nutrition 0.000 claims description 3
- 240000004244 Cucurbita moschata Species 0.000 claims description 3
- 235000009854 Cucurbita moschata Nutrition 0.000 claims description 3
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 claims description 3
- 244000088415 Raphanus sativus Species 0.000 claims description 3
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims description 3
- 244000061456 Solanum tuberosum Species 0.000 claims description 3
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 3
- 235000015136 pumpkin Nutrition 0.000 claims description 3
- 240000006394 Sorghum bicolor Species 0.000 claims 1
- 244000098338 Triticum aestivum Species 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 206010010774 Constipation Diseases 0.000 abstract description 25
- 230000001850 reproductive effect Effects 0.000 abstract description 25
- 230000000694 effects Effects 0.000 abstract description 20
- 229920000642 polymer Polymers 0.000 abstract description 20
- 239000000835 fiber Substances 0.000 abstract description 16
- 235000012054 meals Nutrition 0.000 abstract description 6
- 235000013311 vegetables Nutrition 0.000 abstract description 6
- 235000013339 cereals Nutrition 0.000 abstract description 5
- 230000000968 intestinal effect Effects 0.000 abstract description 5
- 241000894006 Bacteria Species 0.000 abstract description 4
- 244000046052 Phaseolus vulgaris Species 0.000 abstract 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 235000013616 tea Nutrition 0.000 description 27
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 18
- 235000013305 food Nutrition 0.000 description 17
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 16
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 10
- 239000011575 calcium Substances 0.000 description 10
- 229910052791 calcium Inorganic materials 0.000 description 10
- 235000001465 calcium Nutrition 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 10
- 230000008901 benefit Effects 0.000 description 9
- 229910052742 iron Inorganic materials 0.000 description 9
- 235000018102 proteins Nutrition 0.000 description 9
- 108090000623 proteins and genes Proteins 0.000 description 9
- 102000004169 proteins and genes Human genes 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- 239000008280 blood Substances 0.000 description 8
- 150000001720 carbohydrates Chemical class 0.000 description 7
- 235000014633 carbohydrates Nutrition 0.000 description 7
- 235000012000 cholesterol Nutrition 0.000 description 7
- 206010012601 diabetes mellitus Diseases 0.000 description 7
- 239000003925 fat Substances 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 5
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 5
- 241000209140 Triticum Species 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 208000017169 kidney disease Diseases 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 239000011574 phosphorus Substances 0.000 description 5
- 229910052698 phosphorus Inorganic materials 0.000 description 5
- 235000014786 phosphorus Nutrition 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- -1 Korea Polymers 0.000 description 4
- 208000008589 Obesity Diseases 0.000 description 4
- 240000003829 Sorghum propinquum Species 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 208000007502 anemia Diseases 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 210000000941 bile Anatomy 0.000 description 4
- 230000017531 blood circulation Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 208000019423 liver disease Diseases 0.000 description 4
- 235000020824 obesity Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 229940109850 royal jelly Drugs 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 235000019640 taste Nutrition 0.000 description 4
- 235000019155 vitamin A Nutrition 0.000 description 4
- 239000011719 vitamin A Substances 0.000 description 4
- 235000019156 vitamin B Nutrition 0.000 description 4
- 239000011720 vitamin B Substances 0.000 description 4
- 239000002699 waste material Substances 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- 241000238557 Decapoda Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000004913 activation Effects 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 210000004204 blood vessel Anatomy 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 229930002875 chlorophyll Natural products 0.000 description 3
- 235000019804 chlorophyll Nutrition 0.000 description 3
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001784 detoxification Methods 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 230000001766 physiological effect Effects 0.000 description 3
- JZRWCGZRTZMZEH-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 206010019133 Hangover Diseases 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 235000001715 Lentinula edodes Nutrition 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229930003270 Vitamin B Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- 235000019606 astringent taste Nutrition 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- 230000001164 bioregulatory effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000002421 cell wall Anatomy 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 239000000460 chlorine Substances 0.000 description 2
- 229910052801 chlorine Inorganic materials 0.000 description 2
- 230000001906 cholesterol absorption Effects 0.000 description 2
- 206010061428 decreased appetite Diseases 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 230000035622 drinking Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 230000037149 energy metabolism Effects 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 229960002442 glucosamine Drugs 0.000 description 2
- 230000003394 haemopoietic effect Effects 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036543 hypotension Effects 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000005036 nerve Anatomy 0.000 description 2
- 208000004296 neuralgia Diseases 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229920001542 oligosaccharide Polymers 0.000 description 2
- 150000002482 oligosaccharides Chemical class 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 235000007686 potassium Nutrition 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- LCTORNIWLGOBPB-DVKNGEFBSA-N (2s,3r,4s,5s,6r)-2-amino-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound N[C@@]1(O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O LCTORNIWLGOBPB-DVKNGEFBSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 1
- 241000254032 Acrididae Species 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 241000239290 Araneae Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 241000555825 Clupeidae Species 0.000 description 1
- 241001149724 Cololabis adocetus Species 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 241000254043 Melolonthinae Species 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- BNSTVBLCTRZUDD-KEWYIRBNSA-N N-[(3R,4S,5S,6R)-2,3,4,5-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl]acetamide Chemical compound CC(=O)NC1(O)O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O BNSTVBLCTRZUDD-KEWYIRBNSA-N 0.000 description 1
- 206010029333 Neurosis Diseases 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 206010036018 Pollakiuria Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 241000121220 Tricholoma matsutake Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- UGXQOOQUZRUVSS-ZZXKWVIFSA-N [5-[3,5-dihydroxy-2-(1,3,4-trihydroxy-5-oxopentan-2-yl)oxyoxan-4-yl]oxy-3,4-dihydroxyoxolan-2-yl]methyl (e)-3-(4-hydroxyphenyl)prop-2-enoate Chemical compound OC1C(OC(CO)C(O)C(O)C=O)OCC(O)C1OC1C(O)C(O)C(COC(=O)\C=C\C=2C=CC(O)=CC=2)O1 UGXQOOQUZRUVSS-ZZXKWVIFSA-N 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001450 anions Chemical class 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229920000617 arabinoxylan Polymers 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 210000003719 b-lymphocyte Anatomy 0.000 description 1
- 239000003613 bile acid Substances 0.000 description 1
- 230000000443 biocontrol Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000008131 children development Effects 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 206010009887 colitis Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- 208000010643 digestive system disease Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 208000018685 gastrointestinal system disease Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 230000009401 metastasis Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 208000015238 neurotic disease Diseases 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 235000013322 soy milk Nutrition 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000008521 threonine Nutrition 0.000 description 1
- 230000002537 thrombolytic effect Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 208000022934 urinary frequency Diseases 0.000 description 1
- 230000036318 urination frequency Effects 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 238000004260 weight control Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/14—Tea preparations, e.g. using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/06—Treating tea before extraction; Preparations produced thereby
- A23F3/12—Rolling or shredding tea leaves
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/21—Plant extracts
- A23V2250/214—Tea
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/50—Polysaccharides, gums
- A23V2250/51—Polysaccharide
- A23V2250/511—Chitin, chitosan
Abstract
본 발명은 키토산을 첨가한 차(茶) 조성물에 관한 것이다.The present invention relates to a tea composition to which chitosan is added.
본 발명은 키토산을 첨가한 생식 타입의 차(茶) 조성물에 관한 것으로, 더욱 상세하게는 쌀, 콩, 보리, 율무 등 곡식류와 채소류 등을 익히지 않고 건조 분말화한 후 물에 타서 섭취하는 생식 타입의 차에 고분자 키토산(chitosan)을 첨가함으로써 변비 해소 및 장내 유산균 활성화 등의 효과를 보강한 생식 타입 차 조성물에 관한 것이다.The present invention relates to a reproductive type tea composition to which chitosan is added, and more particularly, to a reproductive type in which dry grains and vegetables, such as rice, beans, barley, and yulmu, are cooked without being cooked and dried. The present invention relates to a reproductive type tea composition supplemented with effects such as eliminating constipation and activating intestinal lactic acid bacteria by adding a chitosan polymer.
따라서 본 발명에 따른 생식 타입 차 조성물은 식사 대용으로 생식 타입 차를 섭취할 경우 섭취량이 1회에 약 40g의 소량인 관계로 섬유질이 부족하여 변비가 발생하는 경우가 있으므로 이와 같은 문제점을 해결할 수 있게 한 것이다.Therefore, the reproductive type tea composition according to the present invention can solve the problem because constipation may occur due to lack of fiber because the intake is about 40g at a time when ingesting the reproductive type tea as a substitute for a meal. It is.
Description
본 발명은 키토산을 첨가한 차(茶) 조성물에 관한 것이다.The present invention relates to a tea composition to which chitosan is added.
본 발명은 곡식류, 채소류, 해조류, 버섯류 등을 열에 익히지 않고 건조 분말화한 후 생분말 상태로 물이나 음료수에 타서 음용하는 생식 타입의 차(茶)에 키토산을 첨가하여, 식사 대용으로 생식 타입의 차를 섭취할 경우 그 섭취량이 소량인 관계로 섬유질이 부족하여 변비가 발생하는 단점을 보완하며 또한 키토산의 여러 가지 생리 활성 효능을 이용하기 위한 생식 타입의 차 조성물에 관한 것이다.The present invention is dry powdered grains, vegetables, algae, mushrooms, etc. without heating, and then added chitosan to the raw type tea (tea) drinking by drinking in water or drink in a raw powder state, to replace the raw type of meal When intake of tea is a small amount in relation to the insufficiency of the constipation occurs due to lack of fiber, and also relates to a tea composition of the reproductive type to take advantage of the various physiological activity of chitosan.
생식이란 열을 가하지 않은 식품으로서 일반적으로 곡식류, 채소류, 해조류 및 버섯류 등을 열에 익히지 않고 건조 분말화한 후 생분말 상태로 물이나 음료수에 타서 먹는 것을 말하며 식품을 익혀서 먹는 화식보다 효소, 비타민이 많으며 에너지 효율이 높은 장점이 있다.Raw foods are foods that do not apply heat. In general, grains, vegetables, algae, and mushrooms are dried and powdered without being heated, and they are eaten in water or drink as raw powder.They contain more enzymes and vitamins than cooked foods. It has the advantage of high energy efficiency.
술, 담배 등 인체에 해로운 기호 식품과 육류, 인스턴트 식품의 과식 등은 노폐물을 많이 만들어내기 때문에 혈액 순환의 장애를 가져와 심장 질환을 일으키는 원인이 된다. 또 오장 육부의 기능을 급격히 약화시키면서 간장병, 폐질환 등을유발하기도 한다.Overeating foods, meats, and instant foods that are harmful to the human body, such as alcohol and cigarettes, produce a lot of waste products, resulting in impaired blood circulation and heart disease. In addition, while the function of the five intestines abruptly, hepatic disease, lung diseases, etc. may be caused.
이럴 때 생식을 하면 다량의 효소와 엽록소를 섭취할 수 있게 되므로 노폐물이 차차 빠져 나오게 된다. 엽록소는 식물의 피라고 할 수 있는데, 인간의 혈액과 유사한 구조로 되어 있어 섭취하면 그대로 혈액으로 바뀐다. 녹색 채소에 많이 들어 있고 항암 효과, 조혈 작용, 해독 작용을 하지만 익혀서 섭취하게 되면 많이 파괴되고 칼슘과 결합해 결석의 원인이 되기도 한다.If you reproduce this way, you will be able to consume large amounts of enzymes and chlorophyll, so waste will gradually come out. Chlorophyll is the blood of a plant, which is similar in structure to human blood. Green vegetables are a lot of anti-cancer effect, hematopoietic effect, detoxification effect, but when ingested and eaten is often destroyed and combined with calcium can cause stones.
이와 같이 노폐물이 빠져나가면 인체는 스스로 정화하는 능력을 회복하게 되어 건강을 되찾을 수 있다. 생식을 하는 사람들의 경우 음식을 익혀 먹는 화식을 하는 사람들에 비해 각종 질병 발생률이 낮다는 연구 결과가 나와 있다.In this way, when waste is released, the body recovers its ability to purify itself and can regain health. Studies have shown that people who reproduce have lower rates of disease than cookers who eat cooked food.
또한 생식을 하면 신진 대사가 활발해져서 세포 재생이 빨라지고 노화가 지연되며, 인체의 독소가 배설되고 혈액 순환이 촉진되어 피부가 고와질 뿐만 아니라 탄력이 생긴다.In addition, reproductive activity is accelerated by the regeneration of cells, the aging delay is delayed, the toxins of the human body is excreted, blood circulation is promoted, the skin is not only hardened, but also elastic.
이와 같이 혈액 속의 노폐물을 제거하고 우리 몸 구석구석까지 깨끗한 혈액을 보내면 세포의 기능이 활발해지고 따라서 머리가 맑아지며 집중력, 지구력 등이 향상된다.In this way, if you remove the waste in the blood and send clean blood to every corner of our body, the function of the cell becomes active, thus clearing the head and improving the concentration and endurance.
그러나 이와 같은 생식은 날 것 그대로 먹으면 흡수율이 떨어지므로 가루를 내서 먹는 것이 좋은데, 대개 식사 대용으로 1회 40g 정도의 소량을 섭취하게 된다.However, such raw foods are eaten raw, so the absorption rate is reduced, it is good to eat the powder, usually eat a small amount of about 40g once a meal.
물론 생식 자체로는 섬유질이 풍부하여 변비 및 숙변 제거에 효과적이지만 일반적으로 생식의 섭취량은 상기에 설명한 바와 같이 1회 40g 정도의 소량이며,화식의 섭취량보다 더 많이 섭취하기가 어려운 게 사실이다. 화식에 비해 맛이 떨어지는 것도 그 이유이지만 적은 양으로도 쉽게 포만감을 느낄 수 있어 아무리 많이 먹으려 해도 화식할 때에 비해 3분의 1이상 먹기가 힘들다.Of course, the reproductive itself is rich in fiber is effective in eliminating constipation and stool, but in general, the intake of the raw material is a small amount of about 40g once as described above, it is true that it is difficult to consume more than the intake of flowering. The reason is that the taste is lower than that of flowers, but even small amounts can make you feel full, so no matter how much you eat, it is hard to eat more than a third.
이와 같이 소량을 섭취하게 되니 섬유질이 부족해져 변비에 걸리는 경우가 많았으며, 이러한 문제점을 해결하기 위해 생식 조성물에 고섬유질 식품인 차전자피나 콩 섬유질과 같은 가공 섬유질을 전체 중량의 약 10% 정도로 첨가하여 사용하는 예가 있지만 변비 해소 기능이 부족하고 맛이 나빠지는 문제, 가격 상승의 문제점이 걸림돌이 되었다.As a result of the small amount of intake, constipation was often caused by lack of fiber, and in order to solve this problem, processed fiber such as chafer blood or soybean fiber, which is a high-fiber food, was added to the reproductive composition at about 10% of the total weight. There is an example, but the lack of constipation elimination function, bad taste, the problem of price rises became an obstacle.
본 발명은 상기의 사항들을 고려하여 안출한 것으로서, 본 발명의 목적은 생식 타입 차에 물에 녹았을 때 고점도의 수용성 섬유질이 되는 고분자 키토산을 첨가함으로써 식사 대용으로 생식 타입의 차를 섭취할 경우 섭취되는 섬유질 양의 부족으로 변비가 발생하기 쉬운 문제를 해결하고, 또한 고분자 키토산의 다양한 약리적 효과를 얻을 수 있는 생식 타입의 차 조성물을 제공하는 데에 있다.The present invention has been made in view of the above matters, and an object of the present invention is to ingest the reproductive type tea as a substitute for meal by adding a polymeric chitosan that becomes a high viscosity water-soluble fiber when dissolved in water. The present invention is to solve the problem of constipation easily caused by the lack of fiber amount, and also to provide a tea composition of the reproductive type that can obtain various pharmacological effects of the polymer chitosan.
이와 같은 목적을 달성하기 위하여 본 발명에 따른 고분자 키토산을 첨가한 생식 타입 차 조성물은 쌀, 콩, 보리, 율무 등 곡식류와 채소류 등을 익히지 않고 건조 분말화한 후 물에 타서 섭취하는 생식 타입의 차에 고분자 키토산을 첨가함으로써 변비 해소 및 장내 유산균 활성화 등의 효과를 보강한 것으로서, 식사 대용으로 생식 타입 차를 섭취할 경우 섭취량이 1회에 약 40g의 소량인 관계로 섬유질이부족하여 변비가 발생하는 경우가 있으므로 이와 같은 문제점을 해결할 수 있게 한 것이다.In order to achieve the above object, the reproductive type tea composition to which the polymer chitosan is added according to the present invention is dried and powdered without ripening grains and vegetables such as rice, soybean, barley, yulmu, and then ingested by burning in water. By adding high-molecular chitosan to the constipation, it is reinforcing the effects of constipation and intestinal lactobacillus activation.In the case of ingesting the reproductive type tea as a substitute for meal, the intake amount is about 40g at a time, so fiber is insufficient and constipation occurs. In some cases, this problem can be solved.
이하 본 발명을 상세하게 설명하면 다음과 같다.Hereinafter, the present invention will be described in detail.
본 발명에 따른 키토산 첨가 생식 타입 차 조성물은 발아 현미 76.2∼89.8중량%, 발아 팥 0.4∼0.7중량%, 발아 밀 0.03∼0.42중량%, 발아 보리 1.0∼8.0중량%, 발아 옥수수 0.5∼5.0중량%, 발아 차조 0.2∼2.4중량%, 발아 수수 0.2∼2.4중량%, 고분자 키토산 분말 0.1∼5.0중량%, 당근 0.1∼0.3중량%, 표고버섯 0.1∼0.3중량%, 석이버섯 0.1∼1.2중량%, 솔잎 0.03∼0.34중량%, 케일 0.1∼0.5중량%, 미역 0.2∼2.4중량%, 김 0.02∼0.24중량%, 명일엽 0.1∼0.3중량%, 감자 0.05∼0.35중량%, 메밀 0.1∼1.0중량% 등을 각각 익히지 않고 생으로 건조하여 분말로 한 것과 로얄 젤리 0.05∼0.5중량%, 젖산 효모 0.4∼1.2중량%, 스테비오사이드 0.02∼0.08중량%로 구성되는 것을 특징으로 한다.The chitosan-added raw type tea composition according to the present invention is 76.2 to 89.8% by weight of germinated brown rice, 0.4 to 0.7% by weight of germinated red bean, 0.03 to 0.42% by weight of germinated wheat, 1.0 to 8.0% by weight of germinated barley, and 0.5 to 5.0% by weight of germinated corn , Germination tea 0.2-2.4 wt%, Germination sorghum 0.2-2.4 wt%, Polymer chitosan powder 0.1-5.0 wt%, Carrot 0.1-0.3 wt%, Shiitake mushroom 0.1-0.3 wt%, Shiitake mushroom 0.1-1.2 wt%, Pine needle 0.03-0.34 wt%, kale 0.1-0.5 wt%, seaweed 0.2-2.4 wt%, seaweed 0.02-0.24 wt%, seaweed 0.1-0.3 wt%, potato 0.05-0.35 wt%, buckwheat 0.1-1.0 wt% It is characterized in that it is composed of raw, dried to a powder, 0.05 to 0.5% by weight of royal jelly, 0.4 to 1.2% by weight of lactic acid yeast, and 0.02 to 0.08% by weight of stevioside.
또한 상기 조성물에 발아 검정깨 0.1∼0.3중량%, 발아 율무 0.1∼0.3중량%, 무 0.01∼0.5중량%, 늙은 호박 0.05∼0.35중량%, 미강 0.1∼2.7중량%를 역시 각각 익히 않고 생으로 건조하여 분말화한 것을 더욱 첨가하여 영양적 측면을 보강할 수 있다.In addition, 0.1 to 0.3% by weight of germinated black sesame seeds, 0.1 to 0.3% by weight of germination rate, 0.01 to 0.5% by weight of radish, 0.05 to 0.35% by weight of old pumpkin, 0.1 to 2.7% by weight of rice bran, respectively, Powdered ones can be added to reinforce nutritional aspects.
키토산은 자연계에 풍부한 천연 자원으로 1,000억톤 이상 생산되고 게, 새우 등과 같은 바다 갑각류와 거미, 개미, 메뚜기 등과 같은 곤충의 외피를 구성하는 주성분이고, 미생물에서는 녹조류, 효모, 사상균 등의 세포벽 성분으로 발견된다. 하등 동물의 껍질에 20∼50%, 하등 식물 세포벽에 45%정도 존재하고 있으며, 수산가공 부산물인 게와 새우 껍질이 주로 키토산 추출용 자원이 되고 있다.Chitosan is a natural resource abundant in nature, producing over 100 billion tons and making up the shell of sea crustaceans such as crabs and shrimps, and insects such as spiders, ants and grasshoppers, and found in cell walls such as green algae, yeast and filamentous fungi in microorganisms. do. 20-50% is found in the shells of lower animals and 45% is found in the cell wall of lower plants. Crab and shrimp shells, which are by-products of fish processing, are mainly used for chitosan extraction.
키토산의 효능과 작용은 한국 식품 공업 협회 발행 식품 공전에 수록되어 있고 보건 복지부에서 24개 건강 보조 식품으로 고시되어 있어 그 효능과 작용은 이미 일반화되어 있다고 볼 수 있다.The effects and effects of chitosan are listed in the Food Code published by the Korea Food Industry Association, and the Ministry of Health and Welfare has been announced as 24 health supplements.
키토산은 생리 활성이 매우 높은 천연 다당류로서 천연물 중 유일한 플러스 이온을 갖는 저분자 화합물인 글루코사민이 수천 개의 고리로 연결되어 있는 거대한 고분자 물질로서 물에는 녹지 않으며 식초나 구연산과 같은 산에 팽윤이 된다. 또한 사람의 소화 효소로는 거의 분해가 되지 않아 소화 흡수가 상당히 어려운 물질이지만 3∼4%는 인체 내의 효소인 키토라아제에 의해 분해되어 글루코사민 형태로 흡수되며 키토산이 올리고당으로 가수 분해되면 수용액에 대단히 잘 녹아 체내 흡수율과 생리 활성이 높아진다.Chitosan is a very high physiologically active natural polysaccharide. It is a huge macromolecular substance in which glucosamine, a low molecular compound having only positive ions among natural products, is connected by thousands of rings. It is insoluble in water and swells in acids such as vinegar or citric acid. In addition, human digestive enzymes are almost indestructible and are difficult to absorb. However, 3 to 4% are degraded by chitolase, an enzyme in the human body, to be absorbed in the form of glucosamine. It melts well and increases the body's absorption rate and physiological activity.
고분자 키토산은 천연 고분자 물질이기 때문에 생체 조절력이 있는데, 생체 조절 식품이란 맛이 좋고 영양을 갖춘 식품이 아니라 질병의 예방과 치료 효과를 갖춘 식품을 말한다. 다시 말하면 3차 기능으로서 면역 강화 작용, 노화 방지, 질병의 회복, 생체 기능 조절의 조건을 갖춘 식품이 여기에 해당된다. 즉, 콩의 단백질에는 콜레스테롤을 내리게 하는 효과가 있으며 정어리, 꽁치 등에 함유되어 있는 EPA는 혈전 용해 작용이 있고 송이 버섯이나 양송이 등의 성분은 면역 활성화 작용을 하기 때문에 생체 조절 식품이라 한다.Since polymer chitosan is a natural polymer, it has bioregulatory power. Biocontrol foods are foods that are not tasty and nutritious foods, but have foods that prevent and treat diseases. In other words, foods that have conditions for enhancing immune function, preventing aging, restoring diseases, and regulating biological functions are included as tertiary functions. In other words, the protein of soybeans have the effect of lowering cholesterol, EPA contained in sardines, saury, etc. are thrombolytic action and components such as pine mushrooms and mushrooms are called immune control foods because they are immune-activated.
플러스(+) 이온 상태인 고분자 키토산은 혈압 상승 원인의 하나인 염소나 콜레스테롤, 담즙산 등의 마이너스(-) 이온과 중금속 등을 흡착하여 체외로 배출시키며 인지질과 결합하여 지방의 흡수를 억제하는 기능을 갖고 있으며 소화 촉진, 알콜 대사 촉진, 암 발생 억제 등 생체 조절 식품으로는 최상의 기능성 식품이라 할 수 있다.Polymeric chitosan, which is in the positive (+) ion state, absorbs negative ions such as chlorine, cholesterol, and bile acids and heavy metals, which are one of the causes of blood pressure, and releases them out of the body, and binds phospholipids to inhibit absorption of fat. It is said to be the best functional food for bioregulatory foods such as promoting digestion, promoting alcohol metabolism, and inhibiting cancer.
대한민국 키틴, 키토산 학회에서 발표한 고분자 키토산의 체내에서의 주작용을 살펴보면 다음과 같다.The chitosan of chitosan, Korea, chitosan presented in the body of the main action is as follows.
1. 장내의 이로운 물질을 활성화시키고 해로운 균을 억제시킨다.1. It activates beneficial substances in the intestine and suppresses harmful bacteria.
2. 장내 염증이나 궤양 부위를 감싸 외부 세균이나 이물질의 공격을 막아주며 세포 생성을 돕는다.2. It protects the intestinal inflammation or ulcer area and prevents the attack of foreign bacteria or foreign substances and helps to produce cells.
3. 음주시 간장을 자극하여 알데하이드를 분해, 숙취를 해소하고 간장을 보호 강화한다.3. When drinking alcohol, it stimulates the liver to break down aldehydes, relieve hangovers, and protect the liver.
4. 장에 낀 숙변을 제거하여 영양의 흡수와 쾌적한 장의 활동을 돕는데 특히 우수하다.4. It is especially good at eliminating stool in the intestine to help the absorption of nutrition and pleasant bowel activity.
5. 농약, 공해 특히 다이옥신 등의 음이온과 강하게 결합하여 체외로 배출시킨다.5. It binds strongly with anions such as pesticides, pollution, especially dioxin, and is discharged out of the body.
6, 식염의 염소 이온과 결합, 배출하므로 담즙의 문제 발생과 콜레스테롤 흡수를 막는다.6, combined with chlorine ions in the salt discharge, preventing bile problems and cholesterol absorption.
7. 장내 잉여분의 담즙과 결합 배출하므로 담즙의 문제 발생과 콜레스테롤 흡수를 막는다.7. Intestinal excess of bile combined with bile discharge prevents the occurrence of bile problems and cholesterol absorption.
8. 혈관 내에서 이온 작용으로 이물질, 콜레스테롤, 혈전을 용해하여 혈압을 조절한다.8. It controls blood pressure by dissolving foreign substances, cholesterol, and blood clots by ionic action in blood vessels.
9. 혈관 내벽에 콜레스테롤과 혈전의 유착을 막아 동맥 경화 등 성인병 유발을 억제한다.9. Prevents adhesion of cholesterol and blood clot to the inner wall of blood vessels to suppress the occurrence of geriatric diseases such as atherosclerosis.
10. 뇌혈관 장해(뇌경색, 뇌출혈) 방지, 뇌세포 활성화로 노인성 치매와 뇌경색을 예방한다.10. Prevention of cerebrovascular disorders (cerebral infarction, cerebral hemorrhage), activation of brain cells to prevent senile dementia and cerebral infarction.
11. 인슐린 생성과 췌장의 생리 리듬을 도와 혈당을 저하시켜 체내 에너지를 증폭시킨다.11. Helps produce insulin and physiological rhythms of the pancreas, lowering blood sugar and boosting body energy.
12. 혈액의 PH(산도)를 조절하여 면역계와 산성 체질을 개선한다.12. Improve the pH (acidity) of the blood and improve the immune system and acid constitution.
13. 면역계의 주역인 T, B 임파구를 활성화시켜 자연 치유력을 향상하므로 항암 효과가 탁월하다.13. It activates T, B lymphocytes, the main role of the immune system, and improves natural healing power, so the anti-cancer effect is excellent.
14. 혈관 내 표면에 접착 분자와 결합 암세포의 전이를 원천 봉쇄한다.14. Block the metastasis of adhesion molecules and binding cancer cells to the surface of blood vessels.
15. 자연 상태의 올리고머는 가장 독소가 강한 독소 호르몬을 중화시킨다.15. Natural oligomers neutralize the strongest toxin hormones.
16. 생체 바이오 리듬(지성, 감성, 생체 리듬)을 조절하여 헝클어진 신체 기능을 바로 잡는다.16. Adjust the bio-rhythm (intelligence, sensitivity, bio-rhythm) to correct the messed-up body function.
이와 같이 다양한 효과가 있는 고분자 키토산을 생식 타입의 차 조성물에 혼합하여 사용함으로써 제품의 기능성을 높이고 변비 등을 예방할 수 있게 되는 것이다.Thus, by using a mixture of polymeric chitosan having a variety of effects in the reproductive type tea composition it is possible to increase the functionality of the product and to prevent constipation.
키토산은 소화 흡수가 어려워 인체 내에서의 이용에 제약을 받는 이유로 화학적 또는 효소적 처리 방법으로 분해하여 N-아세틸 글루코스 아민이나 D-글루코스 아민의 중합도가 1 내지 10인 것을 키토산 단당 또는 이의 올리고당이라고 하는데 이는 수용액에 대단히 잘 녹아 체내 흡수율과 생리 활성이 높아진다. 따라서 과거에는 이와 같은 키토산 올리고당을 선호하는 경향이 있었으나 최근에는 고분자 키토산의 체내 콜레스테롤 흡착 배설 효과 및 변비 해소 등의 효과에 주목하기 시작하여 고분자 키토산의 중요성이 부각되고 있다. 본 발명에서도 키토산의 종류 중 변비 해소나 비만, 콜레스테롤 저하 등의 목적용으로는 고분자 키토산의 효과가 높기 때문에 고분자 키토산을 첨가하여 사용하였다.Chitosan is difficult to digest and absorbed in the human body. Therefore, it is decomposed by chemical or enzymatic treatment, and the degree of polymerization of N-acetyl glucose amine or D-glucose amine is called chitosan monosaccharide or its oligosaccharide. It dissolves very well in aqueous solution and increases the body's absorption rate and physiological activity. Therefore, in the past, such chitosan oligosaccharides tended to be preferred, but recently, attention has been paid to the effects of excretion of cholesterol adsorption and constipation in the body of polymer chitosan, and the importance of polymer chitosan has been highlighted. Also in the present invention, polymer chitosan was added and used because chitosan had a high effect of chitosan for the purpose of eliminating constipation, obesity, lowering cholesterol, and the like.
고분자 키토산은 1일 80mg을 섭취했을 때 섭취자의 약 50%에게 효과가 나타났기 때문에, 고분자 키토산 분말이 함유된 생식 타입의 차를 1회 40g씩 1일 2회 섭취하는 경우를 기준으로 하여 0.1중량% 이상 첨가하도록 하였으며, 키토산의 첨가량이 많을수록 변비 해소 기능이나 키토산의 약리 작용도 높아지지만 5.0중량% 이상을 첨가했을 경우 키토산 특유의 떫은 맛과 높은 점성 때문에 생식 타입 차 조성물 전체의 풍미를 저하시키므로 5.0중량% 이하로 첨가하는 것이 바람직하다.Since high-molecular chitosan was effective for about 50% of the intakers when 80mg of daily intake was taken, 0.1% by weight, based on the intake of 40g, once per day, 40g of raw tea containing high-molecular chitosan powder The higher the amount of chitosan added, the higher the elimination of constipation and the pharmacological action of chitosan. However, when added more than 5.0% by weight, chitosan's unique astringent taste and high viscosity lower the flavor of the whole reproductive type tea composition. It is preferable to add below%.
한편, 본 발명의 주요 조성물인 발아 현미란 현미를 싹틔운 것으로 발아 과정 중 전에 없던 특이한 약효 성분들이 새로 생겨나거나 현저히 증가하게 되어, 아라비녹시란, 감마오리자놀, 클로로피린, SOD, 활성화된 섬유소, 비타민류, 미네랄류 등이 새로 생겨나거나 증가됨으로써 쾌변, 에너지 대사 촉진, 비만, 혈액 순환, 자연 치유력 증진 등의 효능이 있는 것으로 알려졌다.Meanwhile, germinated brown rice, which is the main composition of the present invention, sprouts brown rice, and new and unusually active ingredients that were not present during the germination process are newly formed or increased significantly, such as arabinoxylan, gamma-orizanol, chloropyrin, SOD, activated fiber, New or increased vitamins, minerals, etc. have been known to have the effect of promoting comfort, energy metabolism, obesity, blood circulation, natural healing.
따라서 본 발명에서는 발아 현미를 76.2중량% 이상 첨가하여 그 효능을 충분히 이용하도록 하였으나 다른 조성물과의 맛의 조화를 고려하여 89.8중량% 이하로 첨가하는 것이 바람직하며, 특히 83.95중량%로 첨가하는 것이 가장 바람직하다.Therefore, in the present invention, by adding 76.2% by weight or more of germinated brown rice to fully utilize the efficacy, it is preferable to add 89.8% by weight or less in consideration of the balance of taste with other compositions, and particularly, 83.95% by weight. desirable.
발아 팥은 사포닌, 콜린, 지방산, 비타민 B1, 섬유질 등이 주요 함유 성분으로서 신장병, 위장병, 에너지 대사 촉진, 숙취 해독, 변비 등에 좋은 효과가 있다. 따라서 전체적인 조성물의 첨가량 및 향미의 조화를 고려하여 0.4중량%∼0.7중량%의 범위로 첨가하는 것이 바람직하며, 그 중 0.5중량%로 첨가하는 것이 가장 바람직하다.Germinated red beans are saponin, choline, fatty acids, vitamin B 1 , fiber, etc. The main components are kidney disease, gastrointestinal disease, energy metabolism promotion, hangover detoxification, constipation and so on. Therefore, it is preferable to add in the range of 0.4 weight%-0.7 weight% in consideration of the balance of the addition amount and the flavor of the whole composition, and it is most preferable to add in 0.5 weight% among them.
발아 밀은 식물성 섬유와 비타민 E가 풍부하여 위장을 튼튼하게 하고 노화 방지에도 효과가 있으며 비타민 E의 항산화 작용과 혈중 콜레스테롤치를 떨어드리는 리놀레산의 작용이 있어 동맥경화증을 예방하며 신경을 안정시키는 효능이 있다. 그러나 0.03중량% 이하로 첨가할 경우 발아 밀의 장점을 이용하는 효과가 미약하고 0.42중량% 이상 첨가하면 가격이 비싸지므로 상기 범위내로 첨가하는 것이 바람직하며, 특히 0.2중량%로 첨가하는 것이 가장 바람직하다.Germinated wheat is rich in vegetable fiber and vitamin E, which strengthens the stomach and prevents aging. It also has the antioxidant effect of vitamin E and linoleic acid, which lowers blood cholesterol levels, thus preventing atherosclerosis and stabilizing nerves. . However, when it is added at 0.03% by weight or less, the effect of using the advantages of germinated wheat is insignificant, and when it is added at least 0.42% by weight, it is preferable to add it within the above range, and most preferably, 0.2% by weight.
발아 보리 또한 보리를 싹틔운 것으로서 섬유질, 칼슘, 철분, 비타민 B군 등이 함유되어 있어 설사, 당뇨, 피부, 변비, 혈액 순환 불량 등에 효능이 있어 1.0중량% 이상으로 첨가하되 8.0중량%를 초과할 경우 보리 섬유질 특유의 점성이 너무 강해지므로 상기 범위 내로 첨가하는 것이 바람직하며, 특히 5.0중량%로 첨가하는 것이 가장 바람직하다.Germinated barley is also sprouting barley and contains fiber, calcium, iron, and vitamin B group. It is effective in diarrhea, diabetes, skin, constipation and poor blood circulation. In this case, since the viscosity peculiar to the barley fiber becomes too strong, it is preferable to add it within the above range, and it is particularly preferable to add it at 5.0% by weight.
발아 옥수수는 탄수화물, 지방산, 레시틴, 트레오닌 등이 주요 함유 성분으로 이뇨, 신장병, 당뇨, 방광염 등에 효과가 있는데 전체 조성물과의 영양적 균형을 맞추어 0.5중량% 이상으로 첨가하지만 5.0중량% 이상으로 첨가할 경우 가격이비싸지므로 상기 범위 내로 첨가하는 것이 바람직하며, 특히 3.0중량%로 첨가하는 것이 가장 바람직하다.Germinated maize contains carbohydrates, fatty acids, lecithin, threonine, etc. and is effective in diuresis, kidney disease, diabetes, cystitis, etc. In this case, since the price is expensive, it is preferable to add it within the above range, and most preferably, 3.0 wt%.
발아 차조에는 주로 전분, 환원당 등의 탄수화물과 단백질, 지방, 비타민 B군 및 칼슘, 철 등이 주로 함유되어 있고 당뇨병, 빈뇨, 산후회복, 어린이 발육 촉진 등에 특히 이로운데, 0.2중량%보다 적을 경우 효능이 미약하고 또한 이것 역시 2.4중량% 이상으로 첨가하게 되면 가격 상승이 초래되므로 0.2중량%∼2.4중량%의 범위 내로 첨가하는 것이 바람직하지만 1.0중량%로 첨가하는 것이 가장 바람직하다.Germinated tea contains mainly carbohydrates such as starch and reducing sugars, protein, fat, B vitamins, calcium and iron, and is particularly beneficial for diabetes, urinary frequency, postpartum recovery, and promoting children's development. This feeble addition and addition of 2.4% by weight or more also leads to an increase in price, so it is preferable to add in the range of 0.2% by weight to 2.4% by weight, but most preferably 1.0% by weight.
발아 수수에는 탄수화물, 단백질, 지방, 비타민 B군, 미네랄, 섬유소 등이 함유되어 있으며 심혈관계 및 소화 촉진, 약물 해독 등에 좋은 장점이 있다. 이 또한 0.2중량% 이하로 첨가할 경우 그 효능의 발현이 미약하며 전체 조성물의 조화를 고려하여 2.4중량% 이하로 첨가하되 1.0중량%로 첨가하는 것이 바람직하다.Germinated sorghum contains carbohydrates, proteins, fats, B vitamins, minerals, and fiber, and has good benefits in cardiovascular and digestion and drug detoxification. In addition, when added to 0.2% by weight or less, the expression of its efficacy is weak, and considering the harmony of the whole composition, it is preferred to add it in the amount of 2.4% by weight or less but 1.0% by weight.
발아 검정깨에는 단백질, 지방, 비타민 A, 비타민 C, 칼슘, 인, 철 등이 함유되어 있어 당뇨병, 신장병, 노이로제, 허약자, 간장병, 결핵 등에 효과가 있는 것으로 알려져 있는데, 0.1중량% 이하로 첨가할 경우 그 효능이 미약하고 0.3중량% 이상 첨가하면 가격이 비싸지므로 상기 범위내로 첨가하며 특히 0.2중량%로 첨가하는 것이 바람직하다.Germinated black sesame seeds contain protein, fat, vitamin A, vitamin C, calcium, phosphorus and iron, which are known to be effective for diabetes, kidney disease, neurosis, weakness, liver disease and tuberculosis. In this case, the efficacy is weak and the addition of more than 0.3% by weight, the price is expensive, so it is added within the above range, it is particularly preferred to add 0.2% by weight.
발아 율무는 다른 곡류에 비하여 단백질과 지방이 조금 많은 것이 특징인데 탄수화물은 대부분 찰기가 있는 녹말로 구성되어 있다. 이외에도 지방, 비타민 B1,B2, 칼슘, 철분 등이 함유되어 있어 당뇨, 고혈압, 이뇨, 체중 조절, 신경통 등에 효과가 있는 것으로 알려져 있다. 발아 율무 역시 최소한의 영양적 효과를 고려하여 0.1중량% 이상으로 첨가하되 이것 역시 가격 상승의 경제적 측면을 고려하여 0.3중량% 이하로 첨가하는 것이 바람직하며, 특히 0.2중량%로 첨가하는 것이 가장 바람직하다.Germination rate is slightly higher in protein and fat than other grains. Most carbohydrates are made of cold starch. In addition, it contains fat, vitamin B 1 , B 2 , calcium, iron, etc. It is known to be effective in diabetes, hypertension, diuresis, weight control, neuralgia. The germination rate is also added at 0.1% by weight or more in consideration of the minimum nutritional effect, but it is also preferably added at 0.3% by weight or less in consideration of the economic aspect of the price increase, and particularly preferably 0.2% by weight. .
당근은 탄수화물, 단백질, 비타민류, 칼륨, 칼슘, 인, 철 등이 함유되어 있어 심장병, 저혈압, 신장병, 설사, 소화불량, 식욕부진, 치질, 대장염, 천식 등에 효과가 있므로 첨가하는 것이 바람직하다.Carrots contain carbohydrates, proteins, vitamins, potassium, calcium, phosphorus, iron, etc., so they are effective for heart disease, hypotension, kidney disease, diarrhea, indigestion, anorexia, hemorrhoids, colitis, and asthma. .
표고버섯에는 탄수화물, 단백질, 지방, 비타민, 칼륨, 칼슘, 인, 철 등이 함유되어 있으며 항암, 고혈압, 심장병, 당뇨, 뇌졸중, 뇌신경 강화 등의 효능 이용을 목적으로 첨가하는 것이 바람직하다.Shiitake mushrooms contain carbohydrates, proteins, fats, vitamins, potassium, calcium, phosphorus, iron and the like, and are preferably added for the purpose of taking advantage of the effects of anticancer, hypertension, heart disease, diabetes, stroke, and nerve strengthening.
솔잎은 비타민 A, K, C와 철분, 효소 등이 주로 함유되어 있으며 고혈압, 저혈압, 빈혈, 조혈, 정혈작용, 강장, 콜레스테롤 저하에 효능이 있으므로 첨가하는 것이 바람직하다.Pine needles contain vitamins A, K, C and iron, enzymes, etc., and high blood pressure, hypotension, anemia, hematopoiesis, antistatic action, tonic, cholesterol-lowering is preferable to add.
케일은 탄수화물, 단백질, 비타민류, 칼슘, 철, 엽록소 등이 함유되어 있고 항암, 동맥경화, 간장병, 위장, 비만, 신장병, 빈혈 등에 효능이 있으므로 첨가하는 것이 바람직하다.Kale contains carbohydrates, proteins, vitamins, calcium, iron, chlorophyll, and the like, and is effective in anticancer, arteriosclerosis, liver disease, gastrointestinal, obesity, kidney disease, and anemia.
미역은 단백질, 비타민 A, B1, B2, C, K와 칼슘, 인, 철 등이 함유되어 있고 변비, 비만, 신진대사 촉진, 조혈 작용의 효능이 있으므로 첨가하는 것이 바람직하다.Seaweed contains protein, vitamins A, B 1 , B 2 , C, K and calcium, phosphorus, iron, etc., and it is preferable to add constipation, obesity, metabolism promotion, hematopoietic effect.
김은 비타민 A, B1, B2, C, K와 칼슘, 인 등이 주요 함유 성분으로 위, 십이지장 궤양, 식욕부진, 간장병, 고혈압 등의 효능이 있으므로 첨가하는 것이 바람직하다.Seaweed is a vitamin A, B 1 , B 2 , C, K and calcium, phosphorus and other major components, such as stomach, duodenal ulcers, anorexia, liver disease, high blood pressure, etc., it is preferable to add.
명일엽은 비타민 B군, 플라보노이드, 루테오닌, 이소쿠엘치트린 등이 주요 함유 성분으로서 고혈압, 빈혈, 당뇨, 신경통, 이뇨, 피로 회복의 효능이 있으므로 첨가하는 것이 바람직하다.Myeongil leaf is preferably added because vitamin B group, flavonoids, luteonine, isocelchitrin, etc. are the main ingredients of high blood pressure, anemia, diabetes, neuralgia, diuresis, fatigue recovery.
효모에는 아미노산, 미네랄, 비타민 등이 함유되어 있으며 빈혈, 소화촉진, 아미노산 공급 등의 역할을 하므로 첨가하는 것이 바람직하다.Yeast contains amino acids, minerals, vitamins, and the like, so it is preferable to add anemia, promote digestion, and supply amino acids.
상기 재료들은 영양적 균형 및 맛의 조화, 가격 상승의 경제적 측면을 고려하여 그 첨가 범위를 결정하였으므로 상기 기재한 첨가 범위 이내로 첨가하는 것이 바람직하며, 이 외에 로얄 젤리, 스테비오사이드 등을 첨가함으로써 영양 보강 및 생식 타입 차 조성물의 맛을 보강할 수 있다.Since the ingredients are determined in consideration of nutritional balance, taste harmony, and economic aspects of price increase, it is preferable to add the ingredients within the above-described range, and in addition, royal jelly and stevioside may be added to enhance nutrition. And the taste of the raw type tea composition.
본 발명에 따른 생식 타입 차 조성물의 섭취는 1회 섭취 분량을 40g으로 하여 1일 1∼2회 섭취하는 것이 바람직하며, 섭취시에는 생식 타입 차 조성물 1회 분량 40g을 물 200ml에 넣어 흔들어 섞은 후 마시는데, 물 대신 두유나 우유, 무가당 쥬스 등에 타서 마셔도 된다.Ingestion of the reproductive type tea composition according to the present invention is preferably ingested once a day intake 40g once or twice a day, and when ingested, shake 40g of one dose of reproductive type tea composition in 200ml of water and shake You can drink it with soy milk, milk or sugar-free juice instead of water.
이하 실시예를 통하여 본 발명을 상세하게 설명하면 다음과 같다.Hereinafter, the present invention will be described in detail with reference to the following Examples.
[실시예 1]Example 1
발아 현미 83.95중량%, 발아 팥 0.5중량%, 발아 밀 0.2중량%, 발아 보리 5.0중량%, 발아 옥수수 3.0중량%, 발아 차조 1.0중량%, 발아 수수 1.0중량%, 고분자 키토산 분말 1.5중량%, 당근 0.2중량%, 표고버섯 0.2중량%, 석이버섯 0.2중량%, 솔잎 0.2중량%, 케일 0.2중량%, 미역 1.0중량%, 김 0.1중량%, 명일엽 0.2중량%, 감자 0.2중량%, 메밀 0.2중량% 등을 각각 익히지 않고 생으로 건조하여 분말로 한 것과 로얄 젤리 0.3중량%, 젖산 효모 0.8중량%, 스테비오사이드 0.05중량%를 분말로 한 것을 50메쉬의 체로 통과시킨 다음 V형 혼합기에 넣고 30분간 잘 혼합하여 제품을 완성한 후 1회 섭취량인 40g 분량으로 포장한다.Germinated brown rice 83.95 wt%, germinated red bean 0.5 wt%, germinated wheat 0.2 wt%, germinated barley 5.0 wt%, germinated corn 3.0 wt%, germinated tea 1.0 wt%, germinated sorghum 1.0 wt%, polymer chitosan powder 1.5 wt%, carrot 0.2% by weight, 0.2% by weight shiitake mushrooms, 0.2% by weight mushrooms, 0.2% by weight of pine needles, 0.2% by weight of kale, 1.0% by weight of seaweed, 0.1% by weight of seaweed, 0.2% by weight of fresh day leaves, 0.2% by weight of buckwheat, 0.2% by weight of buckwheat Dried raw without boiled back, powdered, 0.3% by weight of royal jelly, 0.8% by weight of lactic acid yeast, and 0.05% by weight of stevioside were passed through a 50-mesh sieve, and then mixed well for 30 minutes. After the product is completed, package it in 40g servings.
[실시예 2]Example 2
발아 현미 82.15중량%, 발아 팥 0.5중량%, 발아 밀 0.2중량%, 발아 보리 5.0중량%, 발아 옥수수 3.0중량%, 발아 차조 1.0중량%, 발아 수수 1.0중량%, 발아 검정깨 0.2중량%, 발아 율무 0.2중량%, 고분자 키토산 분말 1.5중량%, 당근 0.2중량%, 표고버섯 0.2중량%, 석이버섯 0.2중량%, 솔잎 0.2중량%, 케일 0.2중량%, 미역 1.0중량%, 김 0.1중량%, 명일엽 0.2중량%, 감자 0.2중량%, 메밀 0.2중량%, 무 0.2중량%, 늙은 호박 0.2중량%, 미강 1.0중량% 등을 각각 익히지 않고 생으로 건조하여 분말로 한 것과 로얄 젤리 0.3중량%, 젖산 효모 0.8중량%, 스테비오사이드 0.05중량%를 분말로 한 것을 50메쉬의 체로 통과시킨 다음 V형 혼합기에 넣고 30분간 잘 혼합하여 제품을 완성한 후 1회 섭취량인 40g 분량으로 포장한다.Germinated brown rice 82.15 wt%, germinated red bean 0.5 wt%, germinated wheat 0.2 wt%, germinated barley 5.0 wt%, germinated corn 3.0 wt%, germinated green tea 1.0 wt%, germinated sorghum 1.0 wt%, germinated black sesame 0.2 wt% Yulmu 0.2%, polymer chitosan powder 1.5%, carrot 0.2%, shiitake 0.2%, shiitake 0.2%, pine needles 0.2%, kale 0.2%, brown seaweed 1.0%, seaweed 0.1% 0.2% by weight, 0.2% by weight of potatoes, 0.2% by weight of buckwheat, 0.2% by weight of radish, 0.2% by weight of old pumpkin, 1.0% by weight of rice bran, and dried to raw powder, 0.3% by weight of royal jelly, 0.8% by lactic acid yeast 50% by weight, stevioside 0.05% by weight of the powder through a sieve of 50 mesh, and then put in a V-type mixer well mixed for 30 minutes to complete the product and packaged in 40g of one intake.
[실시예 3]Example 3
발아 현미 85.35중량%, 고분자 키토산 분말 0.1중량%로 첨가한 것을 제외하고는 상기 실시예 1과 동일한 방법으로 제조하였다.It was prepared in the same manner as in Example 1, except that 85.35% by weight of germinated brown rice and 0.1% by weight of polymer chitosan powder were added.
[실시예 4]Example 4
발아 현미 85.05중량%, 고분자 키토산 분말 0.4중량%로 첨가한 것을 제외하고는 상기 실시예 1과 동일한 방법으로 제조하였다.It was prepared in the same manner as in Example 1, except that 85.05% by weight of germinated brown rice and 0.4% by weight of polymer chitosan powder were added.
[실시예 5]Example 5
발아 현미 84.65중량%, 고분자 키토산 분말 0.8중량%로 첨가한 것을 제외하고는 상기 실시예 1과 동일한 방법으로 제조하였다.It was prepared in the same manner as in Example 1, except that 84.65% by weight of germinated brown rice and 0.8% by weight of polymer chitosan powder were added.
[실시예 6]Example 6
발아 현미 82.45중량%, 고분자 키토산 분말 3.0중량%로 첨가한 것을 제외하고는 상기 실시예 1과 동일한 방법으로 제조하였다.It was prepared in the same manner as in Example 1, except that the germinated brown rice was added at 82.45% by weight and 3.0% by weight of the polymer chitosan powder.
[실시예 7]Example 7
발아 현미 80.45중량%, 고분자 키토산 분말 5.0중량%로 첨가한 것을 제외하고는 상기 실시예 1과 동일한 방법으로 제조하였다.It was prepared in the same manner as in Example 1, except that 80.45% by weight of germinated brown rice and 5.0% by weight of polymer chitosan powder were added.
[비교예 1]Comparative Example 1
발아 현미를 85.45중량%로 첨가하고 고분자 키토산 분말을 첨가하지 않은 것을 제외하고는 상기 실시예 1과 동일한 방법으로 제조하였다.It was prepared in the same manner as in Example 1 except that the germinated brown rice was added at 85.45% by weight and no polymer chitosan powder was added.
[비교예 2]Comparative Example 2
발아 현미 85.4중량%, 고분자 키토산 분말 0.05중량%로 첨가한 것을 제외하고는 상기 실시예 1과 동일한 방법으로 제조하였다.It was prepared in the same manner as in Example 1, except that 85.4 wt% of germinated brown rice and 0.05 wt% of polymer chitosan powder were added.
[비교예 3]Comparative Example 3
발아 현미 79.45중량%, 고분자 키토산 분말 6.0중량%로 첨가한 것을 제외하고는 상기 실시예 1과 동일한 방법으로 제조하였다.It was prepared in the same manner as in Example 1, except that 79.45% by weight of germinated brown rice and 6.0% by weight of polymer chitosan powder were added.
상기 실시예 1, 2, 3, 4, 5 및 비교예 1, 2의 방법으로 제조한 고분자 키토산 첨가 생식 타입의 차 조성물을 1회 섭취량은 40g, 1일 2회 섭취를 표준으로 하여 20명에게 1개월간 섭취하도록 하여 그 결과를 표 1에 나타내었다.Example 1, 2, 3, 4, 5 and Comparative Example 1, 2 prepared by the method of the polymeric chitosan-added reproductive type tea composition once intake 40 g, twice a day as a standard to 20 people Intake for 1 month and the results are shown in Table 1.
표 1의 결과에서 알 수 있듯이 키토산을 0.1중량%로 첨가한 생식 타입의 차 섭취시 전체 인원 중 약 55%가 변비가 개선된 것으로 나타났으며 그 첨가량이 증가할수록 변비의 개선 효과도 현저히 좋아진 것으로 관찰되었다.As can be seen from the results of Table 1, about 55% of the total number of people in the reproductive type tea supplemented with 0.1% by weight of chitosan improved constipation. Was observed.
고분자 키토산 분말을 1.5중량% 첨가했을 때는 모든 실험자의 변비 개선 효과가 나타났으며, 잔변감이 남아있거나 배변이 힘든 증상도 거의 사라진 것으로 나타났다.When 1.5 wt% of the polymer chitosan powder was added, all the constipation effects of all the experiments were improved, and residual symptoms or hard to defecate were almost disappeared.
비교예 1과 비교예 2의 경우 일부 실험자에게 배변 횟수가 1일 1회로 증가하는 현상이 나타났지만 전체 실험자에 비해 그 비율이 미약하므로 변비 치료효과를 강화할 필요성이 있는 것으로 판단되었다.In Comparative Example 1 and Comparative Example 2, the number of bowel movements increased once a day to some experimenters, but the ratio was weak compared to the entire experiment, it was determined that it is necessary to strengthen the constipation treatment effect.
한편 실시예 1에서 전체 실험자의 변비가 개선되는 효과가 나타났기 때문에 키토산의 첨가량이 더욱 많은 실시예 6과 실시예 7, 그리고 비교예 3은 관능검사만 실시하여 기호도를 조사하였다.On the other hand, since the effect of improving the constipation of the entire experiment in Example 1 was shown that Example 6 and Example 7, and Comparative Example 3, the addition amount of chitosan even more, only the sensory test was conducted to examine the degree of preference.
표 2는 15명의 패널 요원에 의한 5점 척도법에 따른 관능 검사 결과의 평균값이다.Table 2 shows the average sensory test results on a 5-point scale by 15 panelists.
표 2의 결과를 보면, 실시예 1, 2, 3, 4, 5는 기호도가 큰 차이를 보이지않으며 전체적으로 좋은 것으로 나타났다. 그러나 실시예 5와 실시예 6에서 고분자 키토산의 첨가량이 많아짐에 따라 고분자 키토산의 떫은 맛과 강한 점성이 생식 타입 차 조성물 전체의 향미에 좋지 않은 영향을 미쳐 기호도가 약간 감소하였으나 변비 해소 기능이 뛰어난 점을 고려하면 바람직한 첨가량이 것으로 판단되었다.Looking at the results of Table 2, Examples 1, 2, 3, 4, 5 did not show a large difference in the degree of preference was found to be good overall. However, as the amount of polymeric chitosan added in Examples 5 and 6 increased, the astringent taste and strong viscosity of the polymeric chitosan adversely affected the flavor of the whole reproductive type tea composition. Considering this, it was determined that the preferred amount of addition.
또한 비교예 1은 기호도는 좋게 나왔지만 표 1의 결과에서 보듯이 변비 해소 효과가 미약하고, 비교예 2와 비교예 3은 고분자 키토산 고유의 향미와 점성이 너무 강하여 기호도가 상당히 안 좋게 나와 가치가 떨어진 것으로 판단되었다.In addition, Comparative Example 1 had a good acceptability, but as shown in the results of Table 1, the effect of reducing constipation was weak, and Comparative Example 2 and Comparative Example 3 had too strong flavor and viscosity inherent in the high molecular chitosan, so that the acceptability was poorly deteriorated. It was judged.
이상에서 본 바와 같이 변비 개선 효과 및 기호도의 양 측면을 고려해 볼 때 실시예 1이 최적 실시예임을 알 수 있었고, 본 발명에 따른 고분자 키토산 첨가 생식 타입의 차 조성물은 변비 개선 효과도 뛰어난 동시에 생식의 장점을 동시에 이용할 수 있는 우수한 생식 타입의 차 조성물임을 확인할 수 있었다.As seen above, considering the constipation improving effect and the preference of both aspects, it can be seen that Example 1 is the optimum embodiment, the polymeric chitosan-added reproductive type tea composition according to the present invention is excellent in constipation improving effect and at the same time It was confirmed that the tea composition of excellent reproductive type that can take advantage of the benefits at the same time.
상기한 바와 같이 이루어지는 본 발명에 의하면, 고분자 키토산 분말을 생식 타입의 차 조성물에 첨가함으로써, 식사 대용으로 생식 타입의 차 섭취시 발생 가능한 변비를 해소할 수 있고 더불어 장내 유산균 활성화, 콜레스테롤 저하 등 키토산의 여러 가지 약리적 효능을 함께 이용할 수 있는 생식 타입의 차를 제공할 수 있다.According to the present invention made as described above, by adding the polymer chitosan powder to the reproductive type tea composition, it is possible to eliminate constipation that may occur when ingesting the reproductive type tea as a substitute for meals, and to activate chitosan such as intestinal lactic acid bacteria activation and cholesterol lowering. Reproductive type teas can be provided that can take advantage of several pharmacological benefits.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020000062363A KR100336645B1 (en) | 2000-10-23 | 2000-10-23 | The composites of raw-type tea containing chitosan |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020000062363A KR100336645B1 (en) | 2000-10-23 | 2000-10-23 | The composites of raw-type tea containing chitosan |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010073983A KR20010073983A (en) | 2001-08-04 |
KR100336645B1 true KR100336645B1 (en) | 2002-05-16 |
Family
ID=19694923
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020000062363A KR100336645B1 (en) | 2000-10-23 | 2000-10-23 | The composites of raw-type tea containing chitosan |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100336645B1 (en) |
-
2000
- 2000-10-23 KR KR1020000062363A patent/KR100336645B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20010073983A (en) | 2001-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100914065B1 (en) | Natural powdered food using wild flowers and beverage thereof | |
CN101991112A (en) | Health-care food capable of stabilizing glucose function after meal | |
CN104872504A (en) | Meal-replacing powder capable of replacing daily diet and having balanced nutrition and preparation method of meal-replacing powder | |
CN110367526A (en) | A kind of low sugar content and high fiber content nutritional meal replacement powder | |
KR101722481B1 (en) | functional cereal containing sweet potato chip, broccoli granule and dietary fiber for constipation improving and manufacturing method thereof | |
KR100336644B1 (en) | The composites of raw-type tea with anti-obese function | |
CN104431170A (en) | Marine bioactive polysaccharide or oligosaccharide granular tea drink for improving metabolic syndrome (six highs and one lipid) | |
CN1718117A (en) | Instant drinking powder contg. black-fungus, oatmeal and spirulina, and its prepn. method | |
KR20130001560A (en) | Process for preparing yacon pickle | |
KR20210035592A (en) | galeusinialeul iyonghan biman haeso gineung-ui saengsigtaib cha joseongmul | |
KR100329011B1 (en) | The composites of raw-type tea containing octacosanol | |
KR20190140737A (en) | Vinegar compositions comprising detox-diet material and manufacturing method thereof | |
CN105982025A (en) | Selenium-enriched rice flour sausages | |
JP2003189816A (en) | Health food using plum fruit and plum seed kernel | |
KR20170024206A (en) | A method for manufacturing functional dietary fiber using the extract of plum and plum beverage manufactured by the same | |
KR100336645B1 (en) | The composites of raw-type tea containing chitosan | |
KR100325584B1 (en) | The composites of raw-type tea with anti-diabetic function | |
KR101622767B1 (en) | Method for Manufacturing Sauce for spiced rib Using dietary Fiber | |
CN107637736A (en) | A kind of kanjak mannan sports drink and preparation method thereof | |
KR100337005B1 (en) | The composites of raw-type tea fortified the function of reducing cholesterol and thrombi | |
CN100515233C (en) | Sea cucumber milk product and its preparation method | |
KR100336650B1 (en) | The composites of raw-type tea with the function of activating the brain and promoting the growth | |
KR100390095B1 (en) | Preparation method of gimchi with aloe gel | |
JP3762364B2 (en) | Health food production method using earthworms and ants | |
KR19980085889A (en) | Obesity-controlled health food containing extracts of copper, red beans, multileaf and upper limb |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
G15R | Request for early opening | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20110503 Year of fee payment: 10 |
|
LAPS | Lapse due to unpaid annual fee |